GPCR
Structure TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
GPCR vs peer average
31/100
GPCR vs. peer average (D vs. C)
Grade spread
A 2 · B 4 · C 1 · D 2 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
LLY is the first available peer comparator.
Commercial incretin incumbent and competitive benchmark, not a like-for-like development-stage valuation peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GPCR
Structure Therapeutics
LLY
Eli Lilly and
Grade
D
B
Momentum
2
90
Value
41
59
Sentiment
54
54
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs LLY
GPCR / LLY
Grade Position
Below peers
GPCR vs. peer average (D vs. C)
31/100
Momentum
2
LLYValue
41
LLYSentiment
54
GPCRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GPCR
LLY is the first peer returned for this comparison set.